NEO212: A NOVEL TEMOZOLOMIDE-PERILLYL ALCOHOL CONJUGATE EXHIBITS SUPERIOR ACTIVITY AGAINST TEMOZOLOMIDE RESISTANT GLIOMAS AND INTRACRANIAL TRIPLE NEGATIVE BREAST CANCER METASTASIS

BACKGROUND: Although the alkylating agent temozolomide (TMZ) has become the standard of care in the treatment of malignant gliomas, its overall efficacy is still limited by development of drug resistance, limited blood brain barrier (BBB) penetrance, and myelotoxicity. Recently, we have synthesized...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chen, Thomas C., Schonthal, Axel H., Hofman, Florence M., Wang, Weijun, Cho, Heeyon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144595/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.48
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi